DNA probes for pre-pro-epidermal growth factor (EGF) and the precursor of the j3 subunit of nerve growth factor (NGF) were used to chromosomally map human and mouse EGF and NGF genes in panels of human-mouse and mouse-Chinese hamster somatib cell hybrids. The EGF and NGF genes were mapped to human chromosomes 4 and 1, respectively, by using human-mouse cell hybrids. A combination of regional mapping using a chrono;some 1 translocation and comparative gene mapping suggests that the human NGF gene is in the p2l-p22
and mouse-Chinese hamster somatib cell hybrids. The EGF and NGF genes were mapped to human chromosomes 4 and 1, respectively, by using human-mouse cell hybrids. A combination of regional mapping using a chrono;some 1 translocation and comparative gene mapping suggests that the human NGF gene is in the p2l-p22.1 region of chromosome 1. In mouseChinese hamster cell hybrids, both genes were assigned to mouse chromosome 3. A knowledge of the chromosomal assignment of these genes should help in our understanding of their regulation and role in development and disease.
Growth factors are required for the proliferation and differentiation of many types of animal cells. There is an unusually high level of epidermal growth factor (EGF) and nerve growth factor (NGF) in the male mouse submaxillaiy gland and there are similarities in their temporal activation during development and regulation by androgens (1, 2) ; however, there is no known structural homology between them. EGF is a 53 amino acid polypeptide that possesses diverse biological activities (1, 3, 4) , and it may function as a fetal growth hormone responsible for the proliferatioh and differentiation of various tissues and organs during late fetal and neonatal development (4) (5) (6) . However, the presence of EGF receptors on the cells of many different fetal and adult tissues (1, 3, 7, 8) suggests that EGF is involved in the growth and function of cells throughout life. The 8 subunit of NGF (, f3NGF) is a 118 amino acid protein required for growth and development of the peripheral nervous system (2, 4, 9, 10) . NGF is believed to be synthesized by end-organs and is then taken up at the presynaptic membrane of responsive neurones and passed by retrograde axonal transport to the cell body, where it promotes neurite outgrowth and the synthesis of neurotransmitters. It has been suggested that NGF may play a role in some tumors and diseases involving the nervous tissue, including neuroblastoma (11) , familial dysautonomia (12) , neurofibromatosis (13) , and intestinal ganglioneuromatosis (14) . Elevated urinary secretion of EGF has been reported in patients with various malignancies (15) .
Cloning and sequencing of mouse submaxillary gland cDNAs encoding EGF and -NGF indicated that these proteins are generated by processing of larger precursors of 1217 and 307 amino acids, respectively (16) (17) (18) (19) . These precursors may produce other biologically active peptides in addition to EGF and.NtGF. To increase our understanding of the regulation of pre-pro-EGF and pre-pro-3-NGF biosynthesis and their role in development and disease, we determined the chromosomal location of human and mouse genes by analyzing their segregation in panels of somatic cell hybrids (20) . Since genes for platelet-derived growth factor and the EGF receptor have been identified as proto-oncogenes (21) (22) (23) , knowledge of the chromosomal assignment of EGF and NGF might suggest a role for these growth factors in oncogenesis. (26) . On the same cell passage, cell hybrids were examined for 31 human chromosome-specific enzyme markers (20) to confirm the chromosome analysis. In the same way, mouse chromosomes were identified by karyotyping and enzyme markers in mouseChinese hamster cell hybrids (25 (17) , which encodes amino acids Proc. NatL Avadl Sci. USA 82 (1985) (NGF corresponds to residues 188-305) of the precursor as well as the oligo(G'C) tail at the 5' end and 8 nucleotides of the 3' untranislated region. 3Plabeled probes were prepared by nick-translation as described (27 and 5), but absent from others (Fig. 1, lane 4) . In an analysis of DNA from 30 cell hybrids containing various human chromosomes, the human EGF sequences segregated consistently only with chromosome 4 ( Table 1) .
MATERIALS AND METHODS
The mouse submaxillary gland pre-pro-f-NGF cDNA clone hybridized to human HindIII 9.5-and 4.5-kb DNA fragments (Fig. 2, lane 5 ). These were distinguishable from mouse 15.5-, 7-, and 5-kb fragments (Fig. 2, lane 4) (19) . DNA from human-mouse cell hybrids retaining the human NGF gene have all five HindIII fragments (Fig. 2, lanes 2  and 3) . Human NGF sequences cosegregated with chromosome 1 in the cell hybrid panel (Table 1) . Thus, the genes for EGF and NGF are located on human chromosomes 4 and 1, respectively.
Chromosomal Assignment of Edf and Nd in the Mouse.
Mouse genes were mapped by analyzing their segregation in a panel of mouse-Chinese hamster cell hybrids. The mouse Egf gene was identified by hybridization to the mouse submaxillary gland pre-pro-EGF cDNA probe. Two major mouse fragments of 13.5 and 8.0 kb (Fig. 3, lane 1) and a Chinese hamster fragment of 15.3 kb (Fig. 3, lane 2 identified in Xba I digests of these DNAs. Analysis of DNA from 14 cell hybrids indicated that the mouse Egf gene was on chromosome 3 ( Table 2) .
The mouse and Chinese hamster NGF (3-subunit genes were identified by hybridization to the mouse submaxillary gland -NGF cDNA probe. This probe hybridized to mouse 15.5-and 7-kb fragments (Fig. 4, lane 5) and Chinese hamster 14.5-and 5.5-kb fragments (Fig. 4, lane 4) Table  1 legend. *Cell hybrids retaining different mouse chromosomes were described (25) . the basis of other evidence and comparative gene mapping data (see Discussion), the human NGF gene is predicted to be localized in the lp22.1-1p21 region.
DISCUSSION
The human genes for pre-pro-EGF and pre-pro-3-NGF were assigned to human chromosomes 4 and 1, respectively. We suggest, in addition, that by combining chromosomal translocation data and comparative mapping evidence human NGF is likely localized in the p22.1 to distal p21 region of chromosome 1 for the following reasons. The distal portion of the human chromosome 1 short arm is in an area of conserved homology with mouse chromosome 4; both include the genes ENO], PGD, GDH, AK2, and PGMJ (31) . This region extends to PGMI (homologous to mouse Pgm-2), which has been localized to human lp22.1 (32) . From approximately lp22.1 towards the centromere, there is a region of homology with mouse chromosome 3 (31) . This region includes AMY] and AMY2 in the human and mouse, and Ngf in the mouse. We previously mapped AMY to human lp2l (33, 34) . In addition to assigning Ngf to mouse chromosome 3, we have used a rat AMY probe (34) (36, 46) . These binding proteins are also androgen-regulated in the mouse submaxillary gland.
Growth factors and their receptors have been implicated in the abnormal regulation and proliferation in malignant cells. Recently, a structural relationship was shown between the viral oncogene v-sis transforming protein and plateletderived growth factor (PDGF) (21, 22) as well as between the v-erb-B oncogene transforming protein and epidermal growth factor receptor (EGFR) (23) . The EGFR gene (c-erb-B) has been assigned to chromosome 7, pll-p13 (37) , and is not linked to human pre-pro-EGF on chromosome 4. The proto-oncogene, c-raf-2, has been located on chromosome 4 (38) , but this is a processed pseudogene and is not likely to be the EGF gene. The T-cell factor (interleukin 2) gene has been assigned to chromosome 4 in the 4q26-q28 region (24, 39) . It will be interesting to determine where EGF and the Tcell growth factor gene (IL2) are located with relation to each other. In addition, it will be important to map the gene(s) for the type 1 transforming growth factor(s) (TGF), which possesses amino acid homology with EGF (40) . There are three proto-oncogenes on human chromosome 1 but none correspond to NGF. The N-ras (NRAS) proto-oncogene at 1p22 has a different sequence than the pre-pro-,fNGF gene (41) . The SK proto-oncogene is located on the long arm of chromosome 1 (1q12) (42) , and LYM of chicken B-cell lymphomas is located at 1p32 (43) . No cancer-related loci have been mapped to chromosome 3 in the mouse. Although there is no evidence that either EGF or NGF is a proto-oncogene, alteration in their structure or expression could still be a predisposing factor in some cancers. In fact, increased serum levels of NGF-like material have been reported in some patients with neurofibromatosis and ganglioneuromatosis (13, 14) and elevated urinary secretion of EGF has been reported in some patients with various malignancies (15) .
Genetic defects in 13-NGF biosynthesis or its regulation have been implicated as a possible cause of inherited neurological diseases, including some forms of neurofibromatosis and familial dysautonomia (9, 44) . Linkage studies in affected families using restriction fragment length polymorphisms associated with the pre-pro-,3NGF gene have excluded a role for this gene in familial dysautonomia (45) . Abnormal EGF biosynthesis has not been associated with any genetic disorders. Continued analysis and isolation of genes encoding growth factors and their receptors will allow us to precisely define the role(s) of growth factors in development and human disease.
